您的位置: 首页 > 农业专利 > 详情页

PREDICTION DE THERAPIE ET OPTIMISATION DU POTASSIUM SERIQUE DANS LA THERAPIE SANGUINE DE L'INSUFFISANCE RENALE, EN PARTICULIER L'HEMODIALYSE A DOMICILE
专利权人:
BAXTER INTERNATIONAL INC.;BAXTER HEALTHCARE S.A.
发明人:
AKONUR, ALP,LEYPOLDT, JOHN KENNETH,LO, YIN-CHENG,AGAR, BARIS UGAR
申请号:
CA2919223
公开号:
CA2919223A1
申请日:
2014.08.08
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充